Quantitation of 1,3-bis(2-chloroethyl)-1-nitrosourea in plasma using high-performance liquid chromatographyYEAGER, R. L; OLDFIELD, E. H; CHATTERJI, D. C et al.Journal of chromatography. 1984, Vol 305, Num 2, pp 496-501, issn 0021-9673Article

Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4'-O-dimethyl-1-O-(4,6-O-2-thenylidene-β-D-glucopyranosyl)epipodophyllotoxin (VM-26) in the treatment of primary and metastatic brain tumorsSTEWART, D. J; GRAHOVAC, Z; VANDENBERG, T et al.Neurosurgery. 1984, Vol 15, Num 6, pp 828-833, issn 0148-396XArticle

CELL CYCLE AGE RESPONSE OF 9L CELLS TO 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA AND MODIFICATION BY ALPHA -DIFLUOROMETHYLORNITHINE = REPONSE DES CELLULES 9L A LA 1,3BIS(2-CHLOROETHYL)-1-NITROSOUREE EN FONCTION DE L'AGE DU CYCLE CELLULAIRE ET MODIFICATION PAR L'ALPHA-DIFLUOROMETHYLORNITHINEBJERKVIG R; OREDSSON SM; MARTON LJ et al.1983; CANCER RESEARCH; ISSN 0008-5472; USA; DA. 1983; VOL. 43; NO 4; PP. 1497-1500; ABS. ENG; BIBL. 13 REF.; GRAPHArticle

THE ASSESSMENT OF RESPONSE OF MURINE TRANSPLANTABLE COLON TUMORS TO COMBINATION CHEMOTHERAPYCOWEN DM; SIEGERSTETTER J; JANIK AC et al.1982; JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; ISSN 0171-5216; DEU; DA. 1982; VOL. 103; NO 2; PP. 119-126; BIBL. 9 REF.Article

The effect of BCNU on the responses of human erythrocytes to six oxidant stressorsBOTT, M; CALABRESE, E. J.Journal of environmental science and health. Part A, Environmental science and engineering. 1988, Vol 23, Num 3, pp 219-230, issn 0360-1226Article

Synthèse et études d'hétérodimères spécifiques des sites abasiques de l'ADN - Potentialisation d'agents alkylants anticancéreux = Synthesis and studies of heterodimers that specifically recognize abasic sites in DNA-Potentiation of antitumour DNA alkylating drugsAlarcon, Karine; Demeunynck, Martine.2000, 231 p.Thesis

Phase I study pilot arms of radiotherapy and carmustine with temozolomide for anaplastic astrocytoma (radiation therapy oncology group 9813): Implications for studies testing initial treatment of brain tumorsCHANG, Susan M; SEIFERHELD, Wendy; BAHARY, Jean-Paul et al.International journal of radiation oncology, biology, physics. 2004, Vol 59, Num 4, pp 1122-1126, issn 0360-3016, 5 p.Article

Synthesis of no-carrier-added carbon-11 SarCNU: the sarcosinamide analog of the chemotherapeutic agent BCNUCONWAY, T; DIKSIC, M.Journal of nuclear medicine. 1988, Vol 29, Num 12, pp 1957-1960, issn 0097-9058Article

The chemopreventive effect of dimethylthiourea against carmustine-induced myelotoxicity in ratsEL-SAYED, El-Sayed M; ABDEL-AZIZ, Abdel-Aziz H; SALEH, Samira et al.Food and chemical toxicology. 2011, Vol 49, Num 9, pp 1965-1969, issn 0278-6915, 5 p.Article

Protective effect of N-acetylcysteine against carmustine-induced myelotoxicity in ratsEL-SAYED, El-Sayed M; ABDEL-AZIZ, Abdel-Aziz H; HELAL, Gouda K et al.Food and chemical toxicology. 2010, Vol 48, Num 6, pp 1576-1580, issn 0278-6915, 5 p.Article

CARBAMOYLATION OF AMINO ACIDS, PEPTIDES, AND PROTEINS BY NITROSOUREAS. = CARBAMOYLATION DES ACIDES AMINES, DES PEPTIDES ET DES PROTEINES PAR LES NITROSOUREESWHEELER GP; BOWDON BJ; STRUCK RF et al.1975; CANCER RES.; U.S.A.; DA. 1975; VOL. 35; NO 11; PP. 2974-2984; BIBL. 1 P. 1/2Article

INTRACAROTID BCNU (NSC-409962): A TOXICITY STUDY IN SIX RHESUS MONKEYSCRAFTS DC; LEVIN VA; NIELSEN S et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 5; PP. 541-545; BIBL. 9 REF.Article

REACTION OF 1,3-BIS (2-CHLOROETHYL)-1-NITROSOUREA WITH SYNTHETIC POLYNUCLEOTIDES.LUDLUM DB; KRAMER BS; WANG J et al.1975; BIOCHEMISTRY; U.S.A.; DA. 1975; VOL. 14; NO 25; PP. 5480-5485; BIBL. 23 REF.Article

THE EFFECT OF CHEMOTHERAPY ON THE GROWTH OF LEUKEMIA L1210. II. PERSISTENCE OF A NITROSOUREA-INDUCED CHANGE IN THE GROWTH CHARACTERISTICS OF TRANSPLANT GENERATIONS = EFFET DE LA CHIMIOTHERAPIE SUR LA CROISSANCE DE LA LEUCEMIE L1210. II. PERSISTENCE D'UNE MODIFICATION INDUITE PAR LA NITROSOUREE DANS LES CARACTERISTIQUES DE CROISSANCE DES GENERATIONS DE TRANSPLANTSDEVITA VT; BRAY DA; BOSTICK F et al.1972; CELL TISSUE KINET.; G.B.; DA. 1972; VOL. 5; NO 6; PP. 459-566; BIBL. 9 REF.Serial Issue

RESPONSE OF METASTATIC MALIGNANT CARCINOID TUMOR TO ADRIAMYCIN (NSC-123127)SOLOMON A; SONODA T; PATTERSON FK et al.1976; CANCER TREATM. REP.; U.S.A.; DA. 1976; VOL. 60; NO 3; PP. 273-276; BIBL. 9 REF.Article

REPRODUCTION AND TERATOLOGY STUDIES WITH ONCOLYTIC AGENTS IN THE RAT AND RABBIT. I. 1,3-BIS (2-CHLOROETHYL)-1-NITROSOUREA (BNCU)THOMPSON DJ; MOLELLO JA; STREBING RJ et al.1974; TOXICOL. APPL. PHARMACOL.; U.S.A.; DA. 1974; VOL. 30; NO 3; PP. 422-439; BIBL. 15 REF.Article

DISAPPEARANCE OF DISSEMINATED PANCREATIC CARCINOMA WITH COMBINED CHEMOTHERAPY = DISPARITION D'UN CANCER DISSEMINE DU PANCREAS AVEC LA CHIMIOTHERAPIE ASSOCIEELOKICH JJ; BROOKS JR.1973; ANN. SURG.; U.S.A.; DA. 1973; VOL. 177; NO 1; PP. 13-14; BIBL. 5REF.Serial Issue

Pattern of recurrence following local chemotherapy with biodegradable carmustine (BCNU) implants in patients with glioblastomaGIESE, Alf; KUCINSKI, Thomas; KNOPP, Ulrich et al.Journal of neuro-oncology. 2004, Vol 66, Num 3, pp 351-360, issn 0167-594X, 10 p.Article

PHASE II EVALUATION OF 1,3-BIS (2-CHLOROETHYL)-1-NITROSOUREA (BCNU; NSC-409962) IN PATIENTS WITH SOLID TUMORSRAMIREZ G; WILSON W; GRAGE T et al.1972; CANCER CHEMOTHERAPY REP., 1; U.S.A.; DA. 1972; VOL. 56; NO 6; PP. 787-790; BIBL. 13REF.Serial Issue

TREATMENT OF METASTATIC EWING'S SARCOMA WITH BCNU = TRAITEMENT DU CANCER D'EWING METASTATIQUE PAR BCNUPALMA J; GAILANI S; FREEMAN A et al.1972; CANCER; U.S.A.; DA. 1972; VOL. 30; NO 4; PP. 909-913; BIBL. 10 REF.Serial Issue

ZUR THERAPIE DES LYMPHOGRANULOMS. CCNU (1-(2-CHLORAETHYL)-3-ZYKLOHEXYL-1-NITROSOUREA) UND BCNU (1,3-BIS (2-CHLOROAETHYL)-1-NITROSOUREA) SOWIE BCNU-KOMBINATIONEN BEIM LYMPHOGRANULOM HODGKIN, STADIUM III UND IV = SUR LE TRAITEMENT DU LYMPHOGRANULOME. CCNU ((CHLORO-2 ETHYL)-1 CYCLOHEXYL-3 NITROSO-1 UREE) ET BCNU (BIS (CHLORO-2 ETHYL)-1,3 NITROSO-1 UREE) AINSI QUE L'ASSOCIATION BCNU DANS LE LYMPHOGRANULOME DE HODGKIN, STADE III ET IVBRUNNER KW; MAURICE P; SONNTAG RW et al.1972; SCHWEIZ. MED. WSCHR.; SCHWEIZ; DA. 1972; VOL. 102; NO 43; PP. 1546-1551; BIBL. 11 REF.Serial Issue

Intracavitary chemotherapy (Gliadel®) for recurrent esthesioneuroblastoma : Case report and review of the literaturePARK, Michael C; WEAVER, Charles E; DONAHUE, John E et al.Journal of neuro-oncology. 2006, Vol 77, Num 1, pp 47-51, issn 0167-594X, 5 p.Article

Visual system toxicity following intra-arterial chemotherapyKUPERSMITH, M. J; FROHMAN, L. P; CHOI, I. S et al.Neurology. 1988, Vol 38, Num 2, pp 284-289, issn 0028-3878Article

Controlled delivery of 1,3-bis(2-chloroethyl)-1-nitrosourea from ethylene-vinyl acetate copolymerYANG, M. B; TAMARGO, R. J; BREM, H et al.Cancer research (Baltimore). 1989, Vol 49, Num 18, pp 5103-5107, issn 0008-5472, 5 p.Article

Co-delivery of Adenovirus and Carmustine by Anionic Liposomes with Synergistic Anti-tumor EffectsZHIRONG ZHONG; YU WAN; SANJUN SHI et al.Pharmaceutical research. 2012, Vol 29, Num 1, pp 145-157, issn 0724-8741, 13 p.Article